Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 27, 2026
Modern molecular profiling recontextualizes the NRG/RTOG 0539 trial and reveals hidden high-risk and radiotherapy-resistant meningiomas.
Journal: Neuro-oncology
Published: January 09, 2026
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma.
Journal: International journal of radiation oncology, biology, physics
Published: November 01, 2024
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
Journal: Neuro-oncology advances
Published: October 27, 2022
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
Journal: Journal of neuro-oncology
Published: September 15, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).
Journal: Neuro-oncology
Published: January 30, 2021
Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813.
Journal: International journal of radiation oncology, biology, physics
Published: January 11, 2021
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 25, 2020
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525.
Journal: Neuro-oncology practice
Published: December 14, 2019
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database.
Journal: Neuro-oncology
Published: February 21, 2018
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
Journal: Neuro-oncology
Published: December 21, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026